Gerburg M Wulf

8PUBLICATIONS
89CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Haematological tumoursMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 30, 2024
Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurin.

Frank G Rücker, Lars Bullinger, Sibylle Cocciardi

|Sep 13, 2024
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma).

Olivier Tournilhac, Bettina Altmann, Birte Friedrichs

|Feb 15, 2024
Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma.

Nico Gagelmann, Danai Dima, Maximilian Merz

|Mar 31, 2023
Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma.

Jason R Westin, Frederick L Locke, Michael Dickinson

|Jul 20, 2021
Comparison Between 5-Azacytidine Treatment and Allogeneic Stem-Cell Transplantation in Elderly Patients With Advanced MDS According to Donor Availability (VidazaAllo Study).

Nicolaus Kröger, Katja Sockel, Christine Wolschke

Pageof 2